| |
| |
|
| Insider
Information: |
Caforio Giovanni |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
435,474 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$20,519,094 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
435,474 |
|
|
| Total
Value |
$20,519,094 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
3
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.5
|
| Percentage
Gain/Loss : |
0.0%
|
 1.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Bristol-Myers Squibb Co |
BMY |
Executive Chair of the... |
2024-03-10 |
432,266 |
|
0 |
Premium* |
|
|
Stryker Corp |
SYK |
Director |
2024-05-09 |
3,208 |
2023-05-04 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
119 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
• – – |
2012-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
404 |
44,636 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
• – – |
2012-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
384 |
45,527 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
• • – |
2013-03-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,648 |
70,141 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Commercial Officer |
• – – |
2014-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,691 |
53,893 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Commercial Officer |
• – – |
2014-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,962 |
66,548 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
EVP & Chief Commercial Officer |
• – – |
2014-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,214 |
71,124 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Operating Officer |
• • – |
2015-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
1,494 |
48,387 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Operating Officer |
• • – |
2015-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,690 |
64,676 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Operating Officer |
• • – |
2015-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
3,692 |
71,920 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2016-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,749 |
82,376 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2016-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
4,165 |
89,938 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2016-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
652 |
135,201 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chief Executive Officer |
• • – |
2017-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
2,436 |
139,953 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
• • – |
2018-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
6,323 |
217,897 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
• • – |
2020-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
20,877 |
556,936 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
• • – |
2021-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
22,035 |
619,061 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2022-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
72,458 |
712,285 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2023-03-10 |
4 |
A |
$0.00 |
$0 |
D/D |
35,144 |
448,529 |
0 |
- |
|
| SYK |
Stryker Corp |
Director |
– • – |
2023-05-10 |
4 |
A |
$0.00 |
$0 |
D/D |
705 |
2,555 |
0 |
- |
|
| SYK |
Stryker Corp |
Director |
– • – |
2024-05-09 |
4 |
A |
$0.00 |
$0 |
D/D |
653 |
3,208 |
0 |
- |
|
| BMY |
Bristol-Myers Squibb Co |
Chairman and CEO |
• • – |
2021-03-22 |
4 |
AS |
$62.20 |
$1,555,000 |
D/D |
(25,000) |
528,980 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2021-09-20 |
4 |
AS |
$60.64 |
$1,516,000 |
D/D |
(25,000) |
483,980 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2022-03-21 |
4 |
AS |
$71.52 |
$1,788,000 |
D/D |
(25,000) |
581,524 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
Board Chair and CEO |
• • – |
2022-09-20 |
4 |
AS |
$69.71 |
$1,742,750 |
D/D |
(25,000) |
476,104 |
0 |
% |
|
| BMY |
Bristol-Myers Squibb Co |
Pres., US Pharmaceuticals |
• – – |
2012-01-03 |
4 |
D |
$35.01 |
$125,301 |
D/D |
(3,579) |
42,739 |
0 |
- |
|
119 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
